Skip to main content
  • Saved

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migrai | JPR

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migrai | JPR

Source : https://www.dovepress.com/updated-evaluation-of-iv-dihydroergotamine-dhe-for-refractory-migraine-peer-reviewed-article-JPR

Rafia Shafqat, Yadira Flores-Montanez, Victoria Delbono, Stephanie J Nahas Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA Correspondence: Stephanie J Nahas 900 Walnut St., Suite 200, Philadelphia, PA 19107-5509, USATel +1 215 955 1960Fax +1 215 906 0335Email stephanie.nahas@jefferson.edu Abstract: Dihydroergotamine (DHE) is an ergot alkaloid derivative of substances produced by rye fungus.